latest news in Biotechnology
Biotech Milestones: Promising Advances in Flu and Pancreatic Cancer Treatments
Cambridge, Thursday, 7 May 2026.
Published yesterday, groundbreaking clinical data reveals an unprecedented survival benefit for a new pancreatic cancer treatment alongside a highly effective flu vaccine, signaling major medical and market breakthroughs.
Monument Therapeutics Secures US Patent for Breakthrough Schizophrenia Treatment
Cambridge, Thursday, 30 April 2026.
Monument Therapeutics has secured US patent exclusivity through 2042 for MT1988. This pioneering treatment utilizes digital biomarkers to uniquely target and treat cognitive impairment associated with schizophrenia.
